Preclinical antitumor activity of ST7612AA1: a novel second generation oral histone deacetylase (HDAC) inhibitor
收藏NIAID Data Ecosystem2026-03-10 收录
官方服务：
资源简介：
assess the efficacy of ST7612AA1 oral pan-histone deacetylase inhibitor (HDACi), with respect to various solid and haematological tumors, and to characterize its mechanism of action GEP analysis of two lymphoma cell lines with and without treatment
创建时间：
2018-08-13
